Bristol-Myers Squibb's market cap is currently $110.46B. The company's EPS TTM is $-4.428; its P/E ratio is ―; and it has a dividend yield of 4.40%. Bristol-Myers Squibb is scheduled to report earnings on February 6, 2025, and the estimated EPS forecast is $1.53. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 24	Dec 23	Dec 22	Dec 21	Dec 20
Income Statement
Total Revenue	$ 48.30B	$ 45.01B	$ 46.16B	$ 46.38B	$ 42.52B
Gross Profit	$ 36.35B	$ 34.31B	$ 36.02B	$ 36.45B	$ 30.75B
Operating Income	$ 0.00	$ 17.24B	$ 10.33B	$ 10.16B	$ 5.13B
EBITDA	$ 3.17B	$ 19.42B	$ 19.23B	$ 20.19B	$ 5.04B
Net Income	$ -8.95B	$ 8.03B	$ 6.33B	$ 6.99B	$ -8.99B
Balance Sheet
Cash & Short-Term Investments	$ 10.86B	$ 12.28B	$ 9.12B	$ 13.98B	$ 14.55B
Total Assets	$ 92.60B	$ 95.16B	$ 96.82B	$ 109.31B	$ 118.48B
Total Debt	$ 51.20B	$ 41.46B	$ 40.72B	$ 45.60B	$ 51.67B
Net Debt	$ 40.85B	$ 30.00B	$ 31.59B	$ 31.62B	$ 37.13B
Total Liabilities	$ 76.22B	$ 65.67B	$ 65.70B	$ 73.31B	$ 80.60B
Stockholders' Equity	$ 16.34B	$ 29.43B	$ 31.06B	$ 35.95B	$ 37.82B
Cash Flow
Free Cash Flow	$ 13.94B	$ 12.65B	$ 11.95B	$ 15.23B	$ 13.30B
Operating Cash Flow	$ 15.19B	$ 13.86B	$ 13.07B	$ 16.21B	$ 14.05B
Investing Cash Flow	$ -21.35B	$ -2.29B	$ -1.06B	$ -538.00M	$ -10.86B
Financing Cash Flow	$ 5.13B	$ -9.42B	$ -16.96B	$ -16.22B	$ -1.15B

Currency in USD

Bristol-Myers Squibb Earnings and Revenue History

Income Statement >

Bristol-Myers Squibb Debt to Assets

Balance Sheet >

Bristol-Myers Squibb Cash Flow

Cash Flow >

Bristol-Myers Squibb Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing